RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset — Somerville, New Jersey

RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset is a clinical research site located in Somerville, New Jersey, United States 08876.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2 Positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset?

RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset conducted?

RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset has 1 clinical trials on record, with 1 currently active. Their work covers HER2 Positive Breast Cancer.

Is RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset accredited by Crixeo Health?

RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about RWJBarnabas Health-Robert Wood Johnson University Hospital, Somerset?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.